Daisuke Taniguchi, Shotaro Shimonaka, Ahmed Imtiaz, Montasir Elahi, Taku Hatano, Yuzuru Imai, Nobutaka Hattori. Legumain/asparaginyl endopeptidase-resistant tau fibril fold produces corticobasal degeneration-specific C-terminal tau fragment. Neurobiology of Disease. 2024. 201. 106686-106686
Ahmed Imtiaz, Shotaro Shimonaka, Mohammad Nasir Uddin, Montasir Elahi, Koichi Ishiguro, Masato Hasegawa, Nobutaka Hattori, Yumiko Motoi. Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer's disease seed-dependent formation of tau aggregates. Frontiers in aging neuroscience. 2024. 16. 1368291-1368291
Kensuke Daida, Shotaro Shimonaka, Kahori Shiba-Fukushima, Jun Ogata, Hiroyo Yoshino, Ayami Okuzumi, Taku Hatano, Yumiko Motoi, Tomoki Hirunagi, Masahisa Katsuno, et al. α-Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid-Binding Property. Movement disorders : official journal of the Movement Disorder Society. 2022. 37. 10. 2075-2085
Yamashita Yuri, Tagai Kenji, Shimada Hitoshi, Shimonaka Shotaro, Yoshino Hiroyo, Li Yuanzhe, Oyama Genko, Saiki Shinji, Hatano Taku, Matsuoka Kiwamu, et al. MAPT p.K298_H299insQ患者におけるタウ凝集の性質と臨床的特徴との関連性(Property of tau aggregation and its relation with clinical features in MAPT p.K298_H299insQ patients). 臨床神経学. 2021. 61. Suppl. S357-S357